brain cancer

Melbourne, Australia & Indianapolis, USA | April 10, 2026 Telix Pharmaceuticals has announced that the U.S. Food and Drug...

CHANHASSEN, Minnesota, April 9, 2026 Alpheus Medical, Inc. has announced the initiation of its Phase 2b randomized clinical trial...

SAN FRANCISCO, CA, March 23, 2026 Siren Biotechnology has announced that the U.S. Food and Drug Administration (FDA) has...